Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid

Mostrar otras versiones (1)

[Image: see text] The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers an opportunity to rapidly identify such compounds. In this work, we have develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorshkov, Kirill, Chen, Catherine Z., Xu, Miao, Carlos de la Torre, Juan, Martinez-Sobrido, Luis, Moran, Thomas, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553038/
https://www.ncbi.nlm.nih.gov/pubmed/33330840
http://dx.doi.org/10.1021/acsptsci.0c00122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553038/
https://www.ncbi.nlm.nih.gov/pubmed/33330840
http://dx.doi.org/10.1021/acsptsci.0c00122

Ejemplares similares